Imugene

A Cancer-Killing Virus Injected Into A Human For The First Time

An experimental¬†cancer-killing virus has been administered to a human patient for the first time, with hopes the testing will ultimately reveal evidence of a new means of successfully fighting cancer tumors in people’s bodies. The drug candidate, called CF33-hNIS (aka Vaxinia), is what’s called an oncolytic virus, a genetically modified virus designed to selectively infect and kill cancer cells while sparing healthy ones.

Join oUR nEWSLETTER & gET A FREEBIE

When you Join TheMorningNews.com Newsletter, We will give you 1 month FREE Subscription to StockAlert101, A premium Stock Alert Platform. No Credit Card Required.

We will not spam you. Only send you quality emails with breaking news. You can unsubscribe anytime.